Current role
Drug Manufacturers - General · Healthcare
Chairman, Board Member
2023-11-14–present
Michael Jerman
Chairman
Mira Pharmaceuticals, Inc. (MIRA)Board Member
Mira Pharmaceuticals, Inc. (MIRA)Equibles does not estimate personal net worth.
About Michael Jerman
Michael Jerman is recorded as Chairman at Mira Pharmaceuticals, Inc. (MIRA) since December 1, 2023 and Board Member at Mira Pharmaceuticals, Inc. (MIRA) since November 14, 2023. Mira Pharmaceuticals, Inc. reported in an 8-K filed November 21, 2024 that Michael Jerman resigned as member of the Board, effective November 18, 2024. Mira Pharmaceuticals, Inc. reported in an 8-K filed December 1, 2023 that Michael Jerman was appointed Chairman of the Audit Committee of the Board, effective December 1, 2023. Mira Pharmaceuticals, Inc. reported in an 8-K filed November 20, 2023 that Michael Jerman was appointed Director, effective November 14, 2023. Mira Pharmaceuticals, Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Mira Pharmaceuticals, Inc. includes Erez Aminov (CEO, Chairman and Board Member), Jude Uzonwanne (CEO), Alan Weichselbaum (CFO) and 7 others.
“On November 18, 2024, Michael Jerman resigned from his position as a member of the doard of directors (the "Board") of MIRA Pharmaceuticals, Inc. (the "Company"), effective immediately.”
“On December 1, 2023, the Board of Directors of the Company unanimously approved the appointment of Mr. Michael Jerman as Chairman of the Audit Committee of the Board.”
Affiliation history
-
Current
2023-12-01–present
-
Current
2023-11-14–present
-
Start not stated–2024-11-18
Company network
Leadership on record at Mira Pharmaceuticals, Inc.
- Erez Aminov CEO, Chairman, Board Member
- Jude Uzonwanne CEO
- Alan Weichselbaum CFO
- Andriy Mushak CFO
- Jim McNulty CFO
- Brian Daly Board Member
- Denil N. Shekhat Board Member
- Denil Nanji Shekhat Board Member
- Denil Nanji Shekhat, M.D. Board Member
- Edward MacPherson Board Member